Approximately 15.5 million Americans have been or currently are on injectable diabetes or weight-loss medications known as ...

Explore how GLP-1 agonists, originally for diabetes, could transform addiction treatment by reducing cravings.

A new study compares the benefits and risks of taking GLP-1 medications for weight loss, including risks of dementia, ...

This suggests that GLP-1 receptor agonists may offer a protective effect against the development of alcohol-related issues, particularly in the early months of treatment[5]. The mechanisms behind ...

Early research suggests GLP-1 drugs could prevent or treat Alzheimer's Disease. Results from a big clinical trial could soon ...

Scouted selects products independently. If you purchase something from our posts, we may earn a small commission. Unless you ...

The condition appears to be triggered when the optic nerve swells, choking off its blood supply because the nerve's pathway ...

The study of more than two million veterans with diabetes details GLP-1 RA use relating to 175 outcomes; without ...

A RECENT population-based analysis has highlighted potential behavioural side effects associated with Glucagon-like peptide 1 ...

Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic. While both medications share this ...

Lean mass constituted 30.8% of total body weight lost for adults who received a GLP-1 drug during a randomized controlled ...